Navigation Links
Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
Date:11/12/2012

INDIANAPOLIS, Nov. 12, 2012 /PRNewswire/ -- Roche Diagnostics, a world leader in pharmaceuticals and diagnostics, announced in June its plans to invest $300 million during the next 10 years in expanding its North American headquarters located on the northeast side of Indianapolis.  The first phase of the project is a new Learning and Development Center, where approximately 1,500 customers from across the nation will be trained each year. 

Mayor Greg Ballard will be joined by Roche Diagnostics President and CEO Jack Phillips along with members of the City-County Council and community leaders to break ground on the expansion and unveil renderings of the new building, which will have a distinct architectural style.  WHO: Mayor Greg BallardJack Phillips, President and CEO, Roche DiagnosticsMembers of City-County CouncilWHEN:Wednesday, November 14, 201210:00 A.M. Eastern Standard TimeWHAT:Groundbreaking Ceremony for Roche Diagnostics Learning and Development CenterWHERE:Roche Diagnostics Campus – Near Entrance 49115 Hague Road, Indianapolis, IndianaRSVP:Please RSVP to Jacque Robertson at jacque.robertson@roche.com or (317) 521-2819Due to limited parking on corporate campus, RSVPs are appreciated.NOTE:Press riser with mult box to be provided.  Principals will be made available to press following event. About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Director, Corporate Communications

Roche Diagnostics

Indianapolis, IN(317) 521-3966 O

(317) 361-7637 Ctodd.siesky@roche.com

  


'/>"/>
SOURCE Roche Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
2. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
3. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
4. Roche cytomegalovirus viral load test now available in US
5. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
6. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
7. Rochester Medical Reports Third Quarter Results
8. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
9. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
10. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
11. Roche announces FDA approval of HIV viral load test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):